Cargando…
Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
Among adverse drug reactions, drug-induced liver injury presents particular challenges because of its complexity, and the underlying mechanisms are still not completely characterized. Our knowledge of the topic is limited and based on the assumption that a drug acts on one molecular target. We have...
Autores principales: | Moya-García, Aurelio A., González-Jiménez, Andrés, Moreno, Fernando, Stephens, Camilla, Lucena, María Isabel, Ranea, Juan A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315637/ https://www.ncbi.nlm.nih.gov/pubmed/35886075 http://dx.doi.org/10.3390/genes13071292 |
Ejemplares similares
-
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012) -
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
por: Ortega-Alonso, Aida, et al.
Publicado: (2016) -
Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
por: Agúndez, José A. G., et al.
Publicado: (2012) -
A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022) -
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods
por: Coelho, Maria Miguel, et al.
Publicado: (2021)